Last Price
0.111
Today's Change
+0.009 (8.82%)
Day's Change
0.109 - 0.157
Trading Volume
263,656,348
Profile
CDT
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. David Joszef Tapolczay Dr. David Joszef Tapolczay
Full Time Employees: 7 7
IPO Date: 2022-03-28 2022-03-28
CIK: 0001896212 0001896212
ISIN: US20678X1063 US20678X1063
CUSIP: 20678X106 20678X106
Beta: 2.09 2.09
Last Dividend: 0.00 0.00
Dcf Diff: 0.07 0.07
Dcf: 0.05 0.05
Description
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
2
CEO Morning Brief
Fed Vice-chair Says Risks to Inflation, Employment Now Balanced
3
CEO Morning Brief
FTX Creditors Emerge as Possible Fillip for Ailing Crypto Market
4
CEO Morning Brief
5
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
